Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Osiris Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Osiris Therapeutics Inc (OSIR-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Sep 2016 Thomson Reuters Stock Report 12 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of OSIRIS THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

30 Sep 2016 Jefferson Research 11 $20.00

ValuEngine Rating and Forecast Report for OSIR

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

Osiris Therapeutics

24 Sep 2016 S&P Capital IQ Quantitative Report 11 $127.00

OSIRIS THERAPEUTICS INC (OSIR=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Value Graph: OSIRIS THERAPEUT -- OSIR

23 Sep 2016 Ford Investor Services, Inc. 1 $12.00

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review Summary Osiris Therapeutics, Inc. (Osiris) is...

19 Sep 2016 GlobalData 46 $300.00

Wright Investors Service Comprehensive Report for Osiris Therapeutics, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Sep 2016 Wright Reports 65 $75.00

Should Investors Steer Clear of the Osiris Therapeutics, Inc.?

05 Sep 2016 Sadif Analytics Prime 12 $25.00